Skip to main content
Research Solutions Inc (RSSS)
Commercial and Professional Services Industrial Goods
Stock AI

Research Solutions Launches Scite MCP: A Game-Changer for Scientific Literature Access

Last updated: February 26, 2026
Taurigo

1. Introduction

On February 26, 2026, Research Solutions Inc. (NASDAQ: RSSS) announced a groundbreaking development in the field of scientific research with the launch of Scite MCP. This innovative platform bridges the gap between artificial intelligence (AI) tools and scholarly literature, empowering researchers and developers to access and evaluate scientific findings seamlessly. The Scite MCP connects to leading AI tools such as ChatGPT, Claude, Microsoft Copilot, and others, paving the way for enhanced reliability in research environments.

2. Addressing Limitations of Current AI Tools

The launch of Scite MCP comes in response to a persistent challenge faced by researchers: while large language models (LLMs) can generate coherent text on a multitude of topics, they often fall short in their coverage of scholarly material. These AI tools struggle to differentiate between well-supported research findings and those that have been contested, leading to potential misinformation in critical research settings.

Josh Nicholson, Chief Strategy Officer at Research Solutions and co-founder of Scite, highlighted this issue: "Researchers are already using AI tools every day - for writing, analysis, coding, and literature review. The problem is that these tools can't tell you which findings are well-supported and which have been contradicted. By connecting Scite's Smart Citations directly to the tools people already use, we're closing that gap."

3. Key Features of Scite MCP

The Scite MCP offers several key capabilities that enhance the integration of AI tools with scientific literature:

  • Trustworthy Research Answers: AI tools integrated with Scite can provide responses backed by specific, verifiable papers, eliminating unsourced claims.
  • Contextual Citations: Users can see not only that a paper was cited but also whether subsequent research supported, mentioned, or contradicted its findings, offering a comprehensive view of the literature.
  • Extensive Literature Coverage: Access to over 250 million scholarly articles, book chapters, preprints, and datasets ensures that users have a wealth of information at their fingertips.
  • Cross-Tool Compatibility: Scite MCP is designed to work seamlessly across various AI tools, including ChatGPT, Claude, Microsoft Copilot, Cursor, and Claude Code, catering to a wide range of users.

4. Availability and Future Expansions

The Scite MCP is currently available to paid Scite subscribers, providing access to Open Access articles. Research Solutions is actively engaging with publishers to expand the platform's coverage to include paywalled content, allowing for a more comprehensive range of scientific literature.

5. Collaboration with Publishers

Research Solutions recognizes the importance of collaboration with publishers to enhance the Scite MCP integration. By positioning Scite as an MCP gateway, publishers can facilitate controlled AI access to their articles, balancing accessibility with intellectual property concerns.

6. Conclusion

The launch of Scite MCP marks a significant advancement in the integration of AI tools with scientific literature, addressing critical shortcomings in the current research landscape. By providing researchers with access to reliable, evidence-backed information, Research Solutions is not only enhancing the quality of research but also accelerating the pace of scientific discovery. For more information about Scite MCP, please visit www.scite.ai/mcp.

Research Solutions Inc. continues to solidify its position as a leading provider of AI-powered research solutions, transforming how researchers engage with scientific literature globally.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.